Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Randomized Phase 2 Study of Combination Atezolizumab and CDX-1127 (Varlilumab) With or Without Addition of Cobimetinib in Previously Treated Unresectable Biliary Tract Cancers

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT04941287
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:27:46.366208+00:00
Published At
2025-05-23T00:00:00+00:00
Record Updated At
2025-05-23
Results Posted At
2025-05-23
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Metastatic Distal Bile Duct Adenocarcinoma", "Metastatic Gallbladder Carcinoma", "Metastatic Intrahepatic Cholangiocarcinoma", "Recurrent Distal Bile Duct Adenocarcinoma", "Recurrent Gallbladder Carcinoma", "Recurrent Intrahepatic Cholangiocarcinoma", "Stage IV Distal Bile Duct Cancer AJCC v8", "Stage IV Gallbladder Cancer AJCC v8", "Stage IV Intrahepatic Cholangiocarcinoma AJCC v8", "Unresectable Liver Carcinoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-05-23"
protocolSection.identificationModule.nctId
"NCT04941287"
protocolSection.identificationModule.officialTitle
"A Randomized Phase 2 Study of Combination Atezolizumab and CDX-1127 (Varlilumab) With or Without Addition of Cobimetinib in Previously Treated Unresectable Biliary Tract Cancers"
protocolSection.statusModule.overallStatus
"ACTIVE_NOT_RECRUITING"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2025-05-23"

Study condition terms

  • Metastatic Distal Bile Duct Adenocarcinoma (protocolSection.conditionsModule.conditions)
  • Metastatic Gallbladder Carcinoma (protocolSection.conditionsModule.conditions)
  • Metastatic Intrahepatic Cholangiocarcinoma (protocolSection.conditionsModule.conditions)
  • Recurrent Distal Bile Duct Adenocarcinoma (protocolSection.conditionsModule.conditions)
  • Recurrent Gallbladder Carcinoma (protocolSection.conditionsModule.conditions)
  • Recurrent Intrahepatic Cholangiocarcinoma (protocolSection.conditionsModule.conditions)
  • Stage IV Distal Bile Duct Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IV Gallbladder Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IV Intrahepatic Cholangiocarcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
  • Unresectable Liver Carcinoma (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.